Douglas Braunstein‘s Hudson Executive Capital sold 205 thousand shares of Atricure Inc. (NASDAQ:ATRC) for more than $32.8 per share.
The details of the filing can be seen below:
Douglas Braunstein And James Woolery
Hudson Executive Capital We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Hudson Executive Capital | 0 | 1,882,494 | 0 | 1,882,494 | 1,882,494 | EXCLUDES CERTAIN SHARES 4.98% |
| HEC Management GP | 0 | 1,882,494 | 0 | 1,882,494 | 1,882,494 | EXCLUDES CERTAIN SHARES 4.98% |
| Douglas L. Braunstein | 0 | 1,882,494 | 0 | 1,882,494 | 1,882,494 | EXCLUDES CERTAIN SHARES 4.98% |
Page 1 of 8 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
(Amendment No. 2)*
AtriCure, Inc.
(Name of Issuer)
Common Stock, par value $.001
(Title of Class of Securities)
04963C209
(CUSIP Number)
Michael D. Pinnisi
Hudson Executive Capital LP
570 Lexington Avenue
New York, NY 10022
Hudson Executive Capital LP
570 Lexington Avenue
New York, NY 10022
with a copy to:
Richard M. Brand
Cadwalader, Wickersham & Taft, LLP
Richard M. Brand
Cadwalader, Wickersham & Taft, LLP
200 Liberty Street
New York, NY 10281
New York, NY 10281
(212) 504-6000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
Authorized to Receive Notices and Communications)
October 5, 2018
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Atricure Inc. (NASDAQ:ATRC)Follow Atricure Inc. (NASDAQ:ATRC)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 8
Loading...
Related Insider Monkey Articles
RA Capital Management Bets Another $20 Million On Kala Pharmaceuticals Inc.
13D Filing: Elliott Associates, L.p. and Mednax Inc. (NYSE:MD)
Zeff Capital vs. Tsr Inc (TSRI) CEO: Who is Trying To Steal the Company From...
Abdiel Capital Is Buying Appian Corp While Other Insiders Are Dumping
